Sight Sciences (SGHT) Stock Analysis

What Sight Sciences does

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.

Key metrics

ETFs linked to SGHT

Broad-market and Healthcare sector ETFs an investor holding Sight Sciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SGHT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Sight Sciences?

Sight Sciences trades under the ticker SGHT on NASDAQ.

Which exchange is SGHT listed on?

SGHT is listed on NASDAQ.

What sector does Sight Sciences operate in?

Sight Sciences is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze SGHT in a portfolio?

PortView shows SGHT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.